{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T16:53:36Z","timestamp":1694624016894},"reference-count":18,"publisher":"Informa UK Limited","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Dermatological Treatment"],"published-print":{"date-parts":[[2001,1,1]]},"DOI":"10.1080\/095466301750163572","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T15:31:10Z","timestamp":1027697470000},"page":"37-40","source":"Crossref","is-referenced-by-count":2,"title":["Topical imiquimod"],"prefix":"10.1080","volume":"12","author":[{"given":"GW","family":"Pearson","sequence":"first","affiliation":[{"name":"Massachusetts General Hospital, Harvard Medical School, Dermatology Clinical Investigations Unit, Cambridge St, MA, Boston, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"RGB","family":"Langley","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital, Harvard Medical School, Dermatology Clinical Investigations Unit, Cambridge St, MA, Boston, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2009,7,12]]},"reference":[{"key":"CIT0001","doi-asserted-by":"crossref","unstructured":"Bernstein DI, Harrison CJ, Effects of the immunomodulating agent R-837 on acute and latent herpes simplex virus type 2 infections. Antimicrob Agents Chemother (1989) 33: 1511-15.","DOI":"10.1128\/AAC.33.9.1511"},{"key":"CIT0002","doi-asserted-by":"crossref","unstructured":"Harrison CJ, Miller RL, Bernstein DI, Posttherapy suppression of genital herpes simplex virus (HSV) recurrences and enhancement of HSV-specific T-cell memory by imiquimod in Guinea pigs. Antimicrob Agents Chemother (1994) 38: 2059-64.","DOI":"10.1128\/AAC.38.9.2059"},{"key":"CIT0003","doi-asserted-by":"crossref","unstructured":"Richwald GA, Imiquimod. Drugs of Today (1999) 35(7): 497-511.","DOI":"10.1358\/dot.1999.35.7.548263"},{"key":"CIT0004","doi-asserted-by":"crossref","unstructured":"Beutner KR, Spruance SL, Hougham AJ et al, Treatment of genital warts with an immune-response modifier (imiquimod).J Am Acad Drematol (1998) 38: 230-9.","DOI":"10.1016\/S0190-9622(98)70243-9"},{"key":"CIT0005","doi-asserted-by":"crossref","unstructured":"Suzuki H, Wang B, Amerio P et al, Imiquimod, a novel immune response modifier induces migration of Langerhans cells. J Invest Dermatol (2000) 114: 135-41.","DOI":"10.1046\/j.1523-1747.2000.00833.x"},{"key":"CIT0006","unstructured":"Tygum KI, Smith SL, Myers JA et al, Percutaneous penetration of [14C] Imiquimod from a single application of cream. Pharm Res (1995) 12(9): s277."},{"key":"CIT0007","doi-asserted-by":"crossref","unstructured":"Edwards L, Ferenczy A, Eron L et al, Self-administered topical 5% Imiquimod cream for external anogenital warts. Arch Dermatol ( 1998) 134: 25-30.","DOI":"10.1001\/archderm.134.1.25"},{"key":"CIT0008","doi-asserted-by":"crossref","unstructured":"Mayers DL, New treatments for genital warts less than ideal. JAMA (1998) 279: 2002-3.","DOI":"10.1001\/jama.279.24.2003"},{"key":"CIT0009","unstructured":"Langley PC, Tyring SK, Smith MH et al, The cost effectiveness of patient-applied versus provider-administered intervention strategies for the treatment of external genital warts. Am J Managed Care (I999) 5(1): 69-77."},{"key":"CIT0010","unstructured":"55th edition (2001) Physicians desk reference. Medical Economic Company Inc. Montvale. NJ."},{"key":"CIT0011","doi-asserted-by":"crossref","unstructured":"Syed SA, Goswami J, Ahmadpour OA et al, Treatment of molluscum contagiosum in males with an analog of imiquimod 1% in cream: a placebo-controlled double-blind study. J Dermatol (1998) 25: 309-13.","DOI":"10.1111\/j.1346-8138.1998.tb02403.x"},{"key":"CIT0012","doi-asserted-by":"crossref","unstructured":"Buckley R, Smith K, Topical imiquimod therapy for chronic giant molluscum contagiosum in a patient with advanced human immunodeficiency virus 1 disease. Arch Dermatol (1999) 135: 1167-9.","DOI":"10.1001\/archderm.135.10.1167"},{"key":"CIT0013","doi-asserted-by":"crossref","unstructured":"Dubin N, Kopf AW, Multivariate risk score for recurrence of cutaneous basal cell carcinomas. Arch Dermatol (1983) 119: 373-7.","DOI":"10.1001\/archderm.119.5.373"},{"key":"CIT0014","doi-asserted-by":"crossref","unstructured":"Beutner KR, Geisse JK, Helman D et al, Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream. J Am Acad Dermatol (1999) 41: 1002-7.","DOI":"10.1016\/S0190-9622(99)70261-6"},{"key":"CIT0015","doi-asserted-by":"crossref","unstructured":"Mackenzie-Wood A de Launey J, Kossard S et al, Safety and efficacy of imiquimod 5% cream for the treatment of Bowen' s disease. J Invest Dermatol (1998) 110:684.","DOI":"10.1016\/S0923-1811(98)84271-0"},{"key":"CIT0016","doi-asserted-by":"crossref","unstructured":"Wagner TL, Ahonen CL, Couture AM et al, Modulation of THl and TH2 cytokine production with the immune response modifiers, R-848 and imiquimod. Cell Immunol (1999) 191: 10-19.","DOI":"10.1006\/cimm.1998.1406"},{"key":"CIT0017","doi-asserted-by":"crossref","unstructured":"Beutner KR, Reitano MV, Richwald GA et al, External genital warts: report of the American Medical Association consensus conference. Clin Infect Dis (1998) 27: 796-806.","DOI":"10.1086\/514964"},{"key":"CIT0018","doi-asserted-by":"crossref","unstructured":"Beutner KR, Tyring SK, Trofatter KF et al, Imiquimod, a patient-applied immune response modifier for treatment of external genital warts. Antimicrob Agents Chemother (1998) 42: 789-94.","DOI":"10.1128\/AAC.42.4.789"}],"container-title":["Journal of Dermatological Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/095466301750163572","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T18:37:44Z","timestamp":1661193464000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/095466301750163572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,1,1]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2001,1,1]]}},"alternative-id":["10.1080\/095466301750163572"],"URL":"https:\/\/doi.org\/10.1080\/095466301750163572","relation":{},"ISSN":["0954-6634","1471-1753"],"issn-type":[{"value":"0954-6634","type":"print"},{"value":"1471-1753","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,1,1]]}}}